HairMax LaserComb Scheduled to Debut on QVC March 16
Lexington International, manufacturer of the HairMax LaserComb®, the FIRST medical device clinically tested and FDA cleared to promote hair growth in both men and women with certain degrees of hair loss, is pleased to announce that the HairMax Lux 9 Hair Growth LaserComb (QVC Item #A225120) is scheduled to make its QVC® debut during Friday Night Beauty on March 16 at 11 PM (ET).
“Hair loss can be a devastating condition, impacting a person's self-image and emotional well-being,” says Veliky, who has been in charge of the clinical studies. “In the past, treatment usually required a prescription drug and options were limited, especially for women. Now the HairMax LaserComb offers an excellent non-drug option.”
The HairMax LaserComb has been tested to be effective for treating hereditary hair loss in both men and women who have a certain degree of hair loss. It has nine medical lasers and is designed for convenient use in the privacy of one’s home, requiring only three treatments per week for 11 minutes per session to be effective. In clinical studies, results were seen in 16 weeks.
“Lexington and QVC have gained recognition for offering some of the most advanced hair care products to people around the world,” says David Michaels, managing director of Lexington. “Since we all are committed to providing innovative and groundbreaking products to consumers, this is an ideal fit.”
During the past 11 years, the HairMax LaserComb has helped hundreds of thousands of individuals in more than 155 countries worldwide treat their hereditary hair loss conditions and enrich their lives.
Wayne Rooney hair transplant June 2011